Nephraegis Therapeutics

Nephris

The company develops therapies for chronic kidney disease in diabetic patients.

Thrasos

This biotherapeutics company develops targeted peptide therapies for the prevention and treatment of kidney diseases for patients with acute and chronic renal conditions.

NephroGenex (BioStratum, Inc.)

This pharmaceutical company develops therapies to treat kidney disease, including a drug candidate for patients with diabetic nephropathy.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

Corvidia Therapeutics

This clinical-stage biotechnology company develops precision therapies for patients with chronic kidney disease who are at high risk of cardiovascular events.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

NirvaMed

NirvaMed develops medical catheters and blood-processing systems to remove contrast media during heart procedures for healthcare providers to protect patient kidneys from damage.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.